Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Subjects With Giant Cell Rich Tumors of Bone
NCT03605199Phase 2Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2018
- Primary completion
- Jun 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of denosumab in Giant Cell Tumor of Bone (GCTB), aneurysmal bone cyst (ABC), central giant cell granuloma (CGCG), sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
denosumab
03
Conditions
Giant Cell Tumor of Bone (GCTB)aneurysmal bone cyst (ABC)central giant cell granuloma (CGCG)
Beyond the preview
Go deeper on NCT03605199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03605199.